INCY
Incyte CorporationNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$19.41B
P/E Ratio
13.68
EPS
$7.10
Beta
0.80
52W High
$112.29
52W Low
$57.77
50-Day MA
$95.65
200-Day MA
$93.63
Dividend Yield
—
Profit Margin
26.70%
Forward P/E
13.00
PEG Ratio
0.36
About Incyte Corporation
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.
Fundamentals
| Revenue (TTM) | $5.36B |
| Gross Profit (TTM) | $2.83B |
| EBITDA | $1.55B |
| Operating Margin | 25.60% |
| Return on Equity | 30.80% |
| Return on Assets | 13.90% |
| Revenue/Share (TTM) | $27.27 |
| Book Value | $26.04 |
| Price-to-Book | 3.44 |
| Price-to-Sales (TTM) | 3.62 |
| EV/Revenue | 2.869 |
| EV/EBITDA | 8.22 |
| Quarterly Earnings Growth (YoY) | 83.80% |
| Quarterly Revenue Growth (YoY) | 20.90% |
| Shares Outstanding | $199.78M |
| Float | $167.39M |
| % Insiders | 1.81% |
| % Institutions | 104.09% |
Historical Volatility
HV 10-Day
28.67%
HV 20-Day
26.92%
HV 30-Day
26.76%
HV 60-Day
31.70%
HV Rank
29.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($108.50 target)
2
Strong Buy9
Buy13
Hold1
Sell1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026